Medicine by Design’s 5th Annual Symposium on Dec. 7 and 8 attracted more than 500 registrants from across North America, and focused on the theme of better science through convergence – the integration of approaches from engineering, science, medicine and other fields to expand knowledge and spark innovation.
Team led by pioneering stem cell scientist is one step closer to the clinic with cell-based therapies for liver disease.
Two-day event celebrates the importance of scientific diversity in creating better science and tackling key grand questions in the field.
Medicine by Design-funded research team says the new treatment approach is not far from clinical trials. This is one of the ways Medicine by Design is transforming human health.
Seven funded projects poised to impact many diseases including cystic fibrosis, ALS and vision loss.
Nanotechnology expert brings rich experience in academia and industry to the Institute of Biomedical Engineering.
Research to impact cancer, Alzheimer’s disease, autism, aneurysm and more.
The Banting and Best Diabetes Centre, University of Toronto (U of T), has published a profile honouring the work of Medicine by Design Executive Director Michael Sefton, who is also a University Professor at the Institute of Biomedical Engineering and the Department of Chemical Engineering & Applied Chemistry at the University of Toronto (U of T).
$300,000 investment will accelerate new therapies and create new research tools.
How do trainees get started on a path toward developing a product or starting a company? What steps do researchers need to take to move their regenerative medicine discoveries from the lab toward clinical impact? These are just some of the questions an expert panel tackled on July 30 at a virtual event titled Translating Research to Impact – Leveraging Our Ecosystem.
Cross-species study shows that Type 2 diabetes drug metformin could change the way childhood brain injury is treated
$3 million investment to initiate answers to key questions that will transform health care
